An Assessment of Gender Equity and Parity Among “Nontraditional” Pathology Awards

Author:

Jacobs Jeremy W1ORCID,Adkins Brian D2ORCID,Allen Elizabeth S3,Parra-Herran Carlos4ORCID,Stephens Laura D3,Woo Jennifer S5ORCID,Booth Garrett S6ORCID

Affiliation:

1. Department of Laboratory Medicine, Yale School of Medicine , New Haven, CT , USA

2. Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern , Dallas, TX , USA

3. Department of Pathology, University of California San Diego , La Jolla, CA , USA

4. Department of Pathology, Brigham and Women’s Hospital , Boston, MA , USA

5. Department of Pathology, City of Hope National Medical Center , Irvine, CA , USA

6. Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, TN , USA

Abstract

Abstract Objective The aim of this study was to assess the gender composition of nontraditional pathology recognition award recipients. Methods Cross-sectional analysis of American Society for Clinical Pathology (ASCP) Top Five 40 Under Forty and The Pathologist Power List award recipients’ gender. Gender was independently analyzed by 2 authors using pronouns. Two analyses were performed: difference in gender parity and difference in gender equity for award recipients. Results From 2014 through 2022, 618 total awards were conferred. Significantly more men than women received an award overall (57.1% vs 42.9%; P < .001). Compared with population benchmarks, awards conferred to US-based nontrainee pathology physicians (men 56.2%, women 43.8%; P = .091) and US-based pathology physician trainees (men 60.5%, women 39.5%; P = .15) are equitable. Conversely, gender inequities exist among awards conferred to US-based nonphysician laboratory professionals (men 51.7%, women 48.3%; P < .001). Conclusion The Pathologist Power List and Top Five ASCP 40 Under Forty awards have not completely achieved gender parity, and gender inequities remain among subgroups.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3